´ëÇѺνſ¬±¸È¸ 7ȸ ½ÉÆ÷Áö¾ö : 2021-07-03±³À°ÀÏÀÚ : 2021-07-03
±³À°Àå¼Ò : ÄÚ¸®¾Æ³ªÈ£ÅÚ, ´ÙÀ̾ƸóµåȦ(2F)
±³À°ÁÖÁ¦ :
´ëÇѺνſ¬±¸È¸ 7ȸ ½ÉÆ÷Áö¾öÁÖÃÖ±â°ü : ´ëÇѳ»ºÐºñÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѺνſ¬±¸È¸
´ã´çÀÚ : À̼ÒÀº
¿¬¶ôó : 02-2039-5705
À̸ÞÀÏ :
soeun.lee@into-on.com ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 60¸í
Èñ¸ÁÆòÁ¡ : 4Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 4 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 30,000¿ø
ºñ°í »çÀüµî·Ï : Àü¹®ÀÇ-30000 / Àü°øÀÇ-10000 / ¿¬±¸¿ø°£È£»ç-10000´çÀϵî·Ï : Àü¹®ÀÇ-40000 / Àü°øÀÇ-20000 / ¿¬±¸¿ø°£È£»ç-20000
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 07-03 ´ÙÀ̾ƸóµåȦ(2F) 13:05~13:30 Primary aldosteronism: Past, Present, and Future ±èÁ¤Èñ ±³¼ö(¼¿ïÀÇ´ë)
±³À°½Ã°£ 07-03 ´ÙÀ̾ƸóµåȦ(2F) 13:30~13:55 Genetics of primary aldosteronism (update/review) ±èÀçÇö ±³¼ö(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 07-03 ´ÙÀ̾ƸóµåȦ(2F) 13:55~14:20 Subtyping of primary aldosteronism ¾Èâȣ ±³¼ö(¼¿ïÀÇ´ë)
Åä·Ð 07-03 ´ÙÀ̾ƸóµåȦ(2F) 14:20~14:30 Q&A, Panel Discussion È«³²±â ±³¼ö ±èÈ¿Á¤ ±³¼ö ±è¹ÎÈñ ±³¼ö ±èÁ¤ÇÑ ±³¼ö ¼¼ºÈ¯ ±³¼ö(¿¬¼¼ÀÇ´ë À»ÁöÀÇ´ë °¡Å縯ÀÇ´ë ¼º±Õ°üÀÇ´ë µ¿¾ÆÀÇ´ë)
ÈÞ½Ä 07-03 ´ÙÀ̾ƸóµåȦ(2F) 14:30~14:45 Coffee Break ()
±³À°½Ã°£ 07-03 ´ÙÀ̾ƸóµåȦ(2F) 14:45~15:10 Pathologic features of adrenal cortical neoplasm Á¤°æõ ±³¼ö(¼¿ïÀÇ´ë)
Åä·Ð 07-03 ´ÙÀ̾ƸóµåȦ(2F) 15:10~15:20 Q&A, Panel Discussion ±è°æ¾Æ ±³¼ö ·ù¿ÁÇö ±³¼ö Á¶È£Âù ±³¼ö ¹ÚÁöÇö ±³¼ö(µ¿±¹ÀÇ´ë ÇѸ²ÀÇ´ë °è¸íÀÇ´ë ÀüºÏÀÇ´ë)
±³À°½Ã°£ 07-03 ´ÙÀ̾ƸóµåȦ(2F) 15:20~15:40 Case Study 1 Primary aldosteronism with bilateral micronodular adrenal hyperplasia and mild autonomous cortisol excess ½Å¼ºÀç ÀüÀÓÀÇ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 07-03 ´ÙÀ̾ƸóµåȦ(2F) 15:40~16:00 Case Study 2When the AVS results do not meet the clinical reasoning ÀåÇѳª ±³¼ö(¼¿ïÀÇ´ë)
Åä·Ð 07-03 ´ÙÀ̾ƸóµåȦ(2F) 16:00~16:10 Q&A, Panel Discussion Á¤°æ¿¬ ±³¼ö ÃÖÀ±¹Ì ±³¼ö ±è°æÁø ±³¼ö(À»ÁöÀÇ´ë ÇѸ²ÀÇ´ë °í·ÁÀÇ´ë)
ÈÞ½Ä 07-03 ´ÙÀ̾ƸóµåȦ(2F) 16:10~16:25 Coffee Break ()
±³À°½Ã°£ 07-03 ´ÙÀ̾ƸóµåȦ(2F) 16:25~16:45 New therapeutic approaches of primary aldosteronism ¹ÚÁ¤È¯ ±³¼ö(ÇѾçÀÇ´ë)
±³À°½Ã°£ 07-03 ´ÙÀ̾ƸóµåȦ(2F) 16:45~17:05 CAH ÃÖÁøÈ£ ±³¼ö(¿ï»êÀÇ´ë)
±³À°½Ã°£ 07-03 ´ÙÀ̾ƸóµåȦ(2F) 17:05~17:25 ACC ±è±Ô¸® ±³¼ö(¼º±Õ°üÀÇ´ë)
Åä·Ð 07-03 ´ÙÀ̾ƸóµåȦ(2F) 17:25~17:35 Q&A, Panel Discussion ¹Úº´°ü ±³¼ö À̽ÃÈÆ ±³¼ö À̱Ծ𠱳¼ö ³²±ÃÀϼº ±³¼ö À̽ÂÈÆ ±³¼ö(¼º±Õ°üÀÇ´ë °¡ÃµÀÇ´ë ¼¿ïÀÇ´ë ¿ï»êÀÇ´ë ¿ï»êÀÇ´ë)
ÈÞ½Ä 07-03 ´ÙÀ̾ƸóµåȦ(2F) 17:35~17:40 Closing Remark ()